.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Teva
Baxter
Federal Trade Commission
Express Scripts
Argus Health
Daiichi Sankyo
US Army
Chubb
Accenture

Generated: November 22, 2017

DrugPatentWatch Database Preview

ACETYLCYSTEINE Drug Profile

« Back to Dashboard

What is the patent landscape for Acetylcysteine, and when can generic versions of Acetylcysteine launch?

Acetylcysteine is a drug marketed by Roxane, Mylan Institutional, Hospira, Fresenius Kabi Usa, Luitpold, Alvogen Inc, Aurobindo Pharma Ltd, and Akorn Inc. and is included in sixteen NDAs.

The generic ingredient in ACETYLCYSTEINE is acetylcysteine. There are three drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the acetylcysteine profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane
ACETYLCYSTEINE
acetylcysteine
SOLUTION;INHALATION, ORAL072621-001Sep 30, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
ACETYLCYSTEINE
acetylcysteine
INJECTABLE;INTRAVENOUS200644-001Nov 7, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
ACETYLCYSTEINE
acetylcysteine
INJECTABLE;INTRAVENOUS203624-001Jun 19, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira
ACETYLCYSTEINE
acetylcysteine
SOLUTION;INHALATION, ORAL073664-001Aug 30, 1994ANRXNoNo► Subscribe► Subscribe► Subscribe
Luitpold
ACETYLCYSTEINE
acetylcysteine
SOLUTION;INHALATION, ORAL072547-001Jul 28, 1995ANRXNoYes► Subscribe► Subscribe► Subscribe
Luitpold
ACETYLCYSTEINE
acetylcysteine
SOLUTION;INHALATION, ORAL072489-001Jul 28, 1995ANRXNoYes► Subscribe► Subscribe► Subscribe
Akorn Inc
ACETYLCYSTEINE
acetylcysteine
INJECTABLE;INTRAVENOUS203173-001Mar 24, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Roxane
ACETYLCYSTEINE
acetylcysteine
SOLUTION;INHALATION, ORAL072622-001Sep 30, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Roxane
ACETYLCYSTEINE
acetylcysteine
SOLUTION;INHALATION, ORAL072323-001Apr 30, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
ACETYLCYSTEINE
acetylcysteine
SOLUTION;INHALATION, ORAL074037-001Aug 30, 1994ANRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
US Army
UBS
Cerilliant
Daiichi Sankyo
Colorcon
Queensland Health
McKesson
Fish and Richardson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot